1. Blanchet C, Lucas M, Julien P, Morin R, Gingras S, Dewailly E. Fatty acid composition of wild and farmed Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss). Lipids 40:529-31, 2005.
2. Dewailly E, Ayotte P, Lucas M, Blanchet C. Risk and benefits from consuming salmon and trout: a Canadian perspective. Food Chem Toxicol 45:1343-1348, 2007.
3. Lands, W. Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease. Ann New York Acad Scis (Blackwell) 1055: 179–192, 2005.
4. Hibbeln JR, Nieminen LRG, Blasbalg TL, Riggs JA and Lands W. Healthy intakes of n−3 and n−6 fatty acids: estimations considering worldwide diversity. Am J Clinl Nutr 83: 1483S–1493S., 2006.
5. Okuyama H, Ichikawa Y, Sun Y, Hamazaki T and Lands W. (2007). ω3 fatty acids effectively prevent coronary heart disease and other late-onset diseases: the excessive linoleic acid syndrome. World Rev Nutr Diet 96: 83–103, 2007.
6. Daley CA, Abbott AC, Doyle P, Nader G and Larson S. A review of fatty acid profile and antioxidant content in grass-fed and grain-fed beef. Nutr J 9:10-22, 2004. http://www.csuchico.edu/agr/grassfedbeef/health-benefits/index.html.
7. Simopoulos, AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy 56: 365–379, 2002.
8. British Nutrition Foundation. 1992. Unsaturated fatty acids: nutritional and physiological significance. The Report of the British Nutrition Foundations’Task Force. London:British Nutrition Foundation.
9. Lands WE. 1992. Biochemistry and physiology of n-3 fatty acids. The FASEB J 6: 2530-2536. (Review).
10. Roche HM. 1999. Unsaturated fatty acids. Proc Nutr Soc 58: 397-401.
11. Galli C, Simopolous AP, editors. Dietary ω3 and ω6 fatty acids. Biological Effects and Nutritional Essentiality. New York (NY): Plenum Press; 1989.
12. 12, Horrocks LA and Yeo YK. 1999. Health benefits of docosahexaenoic acid. Pharmacol Res 40: 211- 25.
13. Simopoulos A.P. 1991. Omega-3 fatty acids in health and disease, and in growth and development. Am J Clin Nutr 54:438-463.
14. Simopoulos, A.P. 1999. Essential fatty acids in health and chronic disease. Am J Clin Nutr, 70(3):560S-569S.
15. Anderson GJ, Connor We, Corliss JD. Docosahexaenoic acid is the preferred dietary n-3 faty acid for the development of the brain and retina. Pediatr Res 27:89-97, 1990.
16. Hornstra, G. 2000. Essential fatty acids in mothers and their neonates. Am J Clin Nutr 71 (Suppl.1): 1262s-1269s.
17. Uauy R and Valenzuela A. 2000. Marine oils: the health benefits of n-3 fatty acids. Nutrition 16: 680-684.
18. Connor W.E. 2000. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71(Suppl. 1): 171s-175.s.
19. Oh R. Practical applications of fish oil (ω-3 fatty acids) in primary care. J Am Board Family Pract 18:28-36; 2005.
20. Freemantle E, Vandal M, Tremblay-Mercier J, Tremblay S, Blachère JC, Bégin ME, Brenna JT, Windust A and Cunnane SC. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostagl Leukotr Essent Fatty Acids 75:213-220, 2006.
21. Angerer P, von Schacky C. 2000. N-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol. 11: 57-63.
22. Barcelli, U, Glas-Greenwalt P and Pollack V. 1985. Enhancing effect of dietary supplement with n-3 f
atty acids on plasma fibrinolysis in normal subjects. Thromb Res 39 :307-12.
23. Beil FU, Terres W, Orgass M and Greten H. 1991. Dietary fish oil lowers lipoprotein(a) in primary hypertriglyceridemia. Atherosclerosis 90 :95-97.
24. Bonaa KH, Bjerve KS, Staume B, Gram IT and Thelle D. 1990. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso Study. N Engl J Med 322 :795-801.
25. Harris, W.S. 1989. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review. J. Lipid Res. 30: 785-807.
26. Harris, W.S. and O’Keefe, J.H. 2001. Cardioprotective effets of omega-3 fatty acids. Nutr Clin Pract 16: 6-12.
27. Hooper L et al. 2006).Risks and benefits of omega-3 fats for mortality, cardio24vascular disease, and cancer: systematic review. Brit Med J 332: 752-760.
28. Kang JX and Leaf A. 1996. The cardiac antiarrhythmic effects of polyunsaturated fatty acid. Lipids 31: S41-44.
29. Knapp, H.R., and FitzGerald, G.A. 1989. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N. Engl. J. Med. 320:1037-43.
30. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747-2757; 2002.
31. Leaf A, Kang JX, Xiao Y-F, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of
prevention of arrhythmias by n-3 fish oils. Circulation 107:2646-2652; 2003.
32. Lemaitre RN, et al. 2002. N-3 polyunsaturated fatty acids, fatal ischemic heart disease and non-fatal myocardial infarction in older adults. The Cardiovascular Health Study. Am J Clin Nutr 76:319-25.
33. Lorgeril M, et al. 1999. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779-85.
34. Rissanen T, et al. 2000. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events. The Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation;102:2677-9.
35. Wang C, Harris WS, Chung M, et al. 2006. n-3 fatty acids from fish or fish-oil supplements but not a-linoleic acid, benefit cardiovascular outcomes in primary and secondary prevention studies: a systematic review. Am J. Clin Nutr 84:5-17.
36. Cleland LG, French JK, Betts WH, Murphy GA and Elliot MJ 1988. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J. Rheumatol. 15:1471-75.
37. Fortin, P.R., Lew, R.A., Liang, M.H., et al. 1995. Validation of a meta-analysis: The effetsc of fish oil in rheumatoid arthritis. J Clin Epidemiol 48:1379-1390.
38. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis & Rheumatism 37:824-829; 1994.
39. Grimble RF. 1998. Nutritional modulation of cytokine biology. Nutrition 14: 634-40.
40. Harbige LS. 1998. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc Nutr Soc. 57: 555-62
41. Heller A, Koch T, Schmeck J, van Ackern K. 1998. Lipid mediators inflammatory disorders. Drugs 55: 487-96.
42. Skoldstam L, Borjesson O, Kjallman A, Seiving B, Akesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scand J Rheum 21:178-185; 1992.
43. Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 27:2343-2346; 2000.
44. Freeman MP. 2000. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry. 12: 159-65.
45. Haag M. 2003. Essential fatty acids and the brain. Can J Psych 48:195-203.
46. Hibbeln Jr. 1998. Fish consumption and major depression. Lancet 351: 1213.
47. Peet, M., Glen I. and Horrobin D.F. Phospholipid Spectrum Disorder in Psychiatry. Marius Press, 1999.
48. Stoll AL, et al. 1999. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56(5): 407–412.
49. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled studies. J Am Coll Nutr 28:525-542, 2009.
50. Lespérance F, Frasure-Smith N, st-Andre E, Turecki G, Lespérance P, Wisniewski SR. THe efficacy of omega-3 supplementation for major depression : a randomized controlled trial. J Clin Psychiatry 2010 Jun 15.
51. Bégin ME. 1987 Effects of polyunsaturated fatty acids and of their oxidation products on cell survival. Chem Phys Lipids 45:269-313.
52. Bégin, ME, Ells G, Das UN and Horrobin DF. 1986 Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 77:1056-1062.
53. Bégin ME, Ells G and Horrobin DF. 1988. Polyunsaturated fatty acid-induced cytotoxicity
54. against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 80 :188-194.
55. Bégin ME, Sircar S and Weber JM. (1994) Greater sensitivity of Human MDR cancer cells to polyunsaturated fatty acids than their
non-MDR counterparts. J Natl Cancer Inst 86: 638-639.
56. Burns CP, Wagner BA. 1993. Effects of exogenous lipids on cancer and cancer chemotherapy. Drug Saf 8: 57-68.
57. Guffy M, North JA. Burns CP. 1984. Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L121-0 murine leukemia cells. Cancer Res 44:1863-6.
58. Jiang WG, Bryce RP, Horrobin DF. 1998. Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Critical Reviews in Oncol Hematol 27: 179-209.
59. Johanning GL. 1996. Modulation of breast cancer cell adhesion by unsaturated fatty acids. Nutrition 12:810-6.
60. Kinsella JE, Black JM. 1993. Effects of polyunsaturated fatty acids on the efficacy of antineoplastic agents toward 15178y lymphoma cells. Biochem Pharmacol 45:1881-7.
61. Plumb JA, Luo W. Kerr DJ. 1993. Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin. Br J Cancer 67:728-33.
62. Rose DP, Connolly JM, Coleman M. 1996. Effect of w-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin Cancer Res 2: 1751-6.
63. Rose DP, Connoly JM, Meschter CL. 1991. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 83:1491-5.
64. Santé Canada. Monographie des suppléments de multivitamines/minéraux. 2007.
65. Preedy VR, Burrow GN and Watson R (eds). Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects, Amsterdam, Academic Press, 2009.
66. Braverman LE and Utiger RD (Eds). Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text. Lippincott, Williams and Wilkins, 2005.
67. Venturi S and Bégin ME. Thyroid hormone, iodine and human brain evolution. In: Cunnane SC. and Stewart KM. Human Brain Evolution, The Influence of Freshwater and Marine Food Resources. Wiley-Blackwell, NJ, 2010.
68. Hulbert AJ. Thyroid hormones and their effects: a new perspective. Biol Rev 75:319-631, 2000.
69. Bégin ME, Langlois MF, Lorrain D and Cunnane SC. Thyroid function and cognition during aging. Curr Gerontol Geriat Res doi:10.1155/2008/474868.
70. Bauer M, London ED, Silverman DHS, Rasgon N, Krichleiner J and Whybrow PC. Thyroid, brain and mood modulation in affective disorders: insights from molecular research and function brain imaging. Pharmacopsychiatry 36:S215-S221, 2003.
71. Abraham GE. The History of Iodine in Medicine Part I: From Discovery to Essentiality.The Original Internist 13:29-36, 2006 .
72. Abraham GE, The History of Iodine in Medicine Part II: The Search for and the Discovery of Thyroid Hormones. The Original Internist 13: 67-70, 2006.
73. Bauer M, Goetez t, Glenn T and Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 20:1101-1114, 2008.
74. Bauer M, Heinz A and Whybrow PC. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry 7:140-156, 2002.
75. Joffre RT and Sokolov ST. Thyroid hormone treatment of primary unipolar depression: a review. Int J Neurophsychopharmacol 3:143-147, 2000.
76. Joffe Rt, Sokolov ST and Levitt AJ. Lithium and triiodothyronine augmentation of antidepressants. Can J Psychiatry 51:791-793, 2006.
77. Stone OJ. The role of the primitive sea in the natural selection of iodides as a regulating factor in inflammation. Medical Hypotheses 25: 125-129,1988.
78. Küpper FC, Carpenter LJ, McFiggans GB et al. Iodide accumulation provides kelp with an inorganic antioxidant impacting atmospheric chemistry. Proc Nat Acad Sci USA 13: 6954-6958, 2008.
79. Venturi S and Venturi M. Iodide, thyroid and stomach carcinogenesis: Evolutionary story of a primitive antioxidant? Eur J Endocrinol 140: 371-372, 1999.
80. Venturi S and Venturi M. Evolution of dietary antioxidant defenses. European Epi-Marker, 1:1-12. 2007.
81. Katamine S, Hoshino N, Totsuka K and Suzuk, M. Effects of the long-term feeding of high-iodine eggs on lipid metabolism and thyroid function in rats. J Nutr Sci Vitaminol 31: 339-345, 1985.
82. Liu Y. Study on antioxidative unbalance and structural damage in iodine deficient rats. 12th International Thyroid Congress, Kyoto, 22-27 October, p. 559, 2000.
83. Liu Y. The damage role of free radical in iodine deficient children.12th International Thyroid Congress, Kyoto, 22-27 October, p.560, 2000.
84. Berking S, Czech N, Gerharz M. et al. A newly discovered oxidant defence system and its involvement in the development of Aurelia aurita (Scyphozoa Cnidaria): reactive oxygen species and elemental iodine control medusa formation. Int J Develop Biol 49: 969-976, 2005.
85. Cash WD, Gardy M, Carlson HE and Ekong EA. (1966) Mitochondrial swelling and lipid peroxidation studies with mixture of thyroxine and micromolar concentration of certain metal ions. J Biol Chem 241:1745-1750, 1966.
86. Oziol L, Faure P, Vergely C et al. In vitro free radical scavenging capacity of thyroid hormones and structural analogues. J Endocrinol
87. Tseng YL and Latham KR. Iodothyronines: oxidative deiodination by hemoglobin and inhibition of lipid peroxidation. Lipids 19:96-102, 1984.
88. Ware CM and Wishner LA. The lipid antioxidant properties of iodine compounds. Lipids 3:182-183,1968.
89. Winkler R, Griebenow S and Wonisch W. Effect of iodide on total antioxidant status of human serum. Cell Biochem Function 18:143-146,2000.
90. Abnet CC, Fan JH, Kamangar F et al. Self-reported goiter is associated with a significantly increased risk of gastric non cardia adenocarcinoma in a large population-based Chinese cohort. International J Cancer 119:1508-1510,2006.
91. Aceves C, Anguiano B and Delgado, G. Is Iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol and Neoplasia 10: 189-196, 2005.
92. Buchberger W, Winkler R, Moser M and Rieger G. Influence of iodide on cataractogenesis in emory mice. Ophthalmic Res 23 : 303-308,1991.
93. Cann SA, Van Netten JP and Van Netten C. Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Control 11: 121-127,2000.
94. Eskin BA. Iodine and mammary cancer. Adv Exp Med Biol 91: 293-304, 1977.
95. Elstner E., Adamczyk R, Krome R and Furch A. The uptake of potassium iodide and its effects as an antioxidant in isolated rabbit eyes. Ophthalmologica 191: 122–126, 1985.
96. Funahashi H, Imai T and Tanaka Y. Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. J Surg Oncol 61: 209-213, 1996.
97. Kessler JH. The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia. Breast J 10: 328-336, 2004.
98. Muranov K, Poliansky N, Winkler R. et al. Protection by iodide of lens from selenite-induced cataract. Graefe’s Arch Clin Experim Ophthalmol 242: 146-151, 2004.
99. Gołkowski F, Szybiński Z, Rachtan J et al. Iodine prophylaxis-the protective factor against stomach cancer in iodine deficient areas. Eur J Nutr 46: 251-256, 2007.
100. Rieger G, Winkler R, Buchberger W and Moser M. Iodine distribution in a porcine eye model following iontophoresis. Ophthalmologica 209 : 84-87, 1995.
101. Venturi S.Is there a role for iodine in breast diseases? The Breast, 10: 379-382, 2001.
102. Venturi S, Donati FM, Venturi A et al. Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Adv Clin Pathol 4 :11-17, 2000.
103. Venturi S, Marani L and Magni MA. Syndrome thyro-gastric: Study on the relation between alimentary iodine deficiency and gastric cancer. In: Epidemiology, Prevention and Early Detection of Gastric Cancer (eds G Ghironzi, CE Jackson, and BM Schuman), CIC Edit., Rome, pp. 272-281, 1987.
104. Smyth PP. The thyroid, iodine and breast cancer. Breast Cancer Re, 5: 235-238, 2003.
105. Smyth PP. Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors 19:121-130, 2003.
106. Bianco AC and Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J Clin Investigation 116: 2571-2579, 2006.
107. Cunnane, S. Survival of the Fattest: The Key to Human Brain Evolution. World Scientific Publishing Company, Singapore, p.115-160, 2005.
108. Cunnane, SC. Human brain evolution: a question of solving key nutritional and metabolic constraints on mammalian brain development. In: Cunnane, SC. and Stewart, KM. (Eds) Human Brain Evolution, The Influence of Freshwater and Marine Food Resources, Wiley-Blackwell , NJ, pp. 33-64, 2010.
111. Bégin ME, Plourde M, Pifferi F and Cunnane SC. Are fish and docosahexaenoic acid linked to lower risk of cognitife decline and Alzheimer’s disease? In: Recent Advances on Nutrition and the Prevention of Alzheimer’s Disease, Ramassamy C and Bastianetto S, eds, Transworld Reasearch Network, Kerala, India p. 71-95, 2010.
112. Féart C, Samieri C and Barberger-Gateau P. Diet and Alzheimer’s disease: New evidence from epidemiological studies. In: Recent Advances on Nutrition and the Prevention of Alzheimer’s Disease, Ramassamy C and Bastianetto S, eds, Transworld Reasearch Network, Kerala, India p. 19-40, 2010.
113. Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res 48:329-256, 2009.
114. Gillette-Guyonnet S, Abellan Van Kan G, Andrieu S, et al. IANA task force on nutrition and cognitive decline with aging. J Nutr Health & Aging 11:132-152, 2007.
115. Cocchi M and Venturi S. Iodide, antioxidant function and omega-6 and omega-3 acids: a new hypothesis of a biochemical cooperation? Prog Nutr 2:15-19, 2000.
116. Hooijmans CR and Kiliaan AJ. Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 585:176-196, 2008.
117. Salem N, Litman B, Kim HY, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36 :945-959, 2001.
118. Bazan NG. Cell survival matters: docosahexaenoic acid signaling,neuroprotection and photoreceptors. Trends Neurosci 29 :263-271, 2006.
119. Bazan NG. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opinion Clin Nutri Metabolic Care 10:136–41, 2007.
120. Fotuhi M, Mohassel P and Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nature Clin Practice Neurol 5:140-152, 2009.
121. Maclean DH, Issa AM, Newberry Sj, Mojica WA, Morton Sc, et al. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. Evid Rep Technol Assess (Summ):1-3, 2005.
122. Ramassamy C, Doggui S, Arsenault M and Dao L. Towards a nutritional approach for the prevention of Alzheimer’s disease: Promise of polyphenolic components. In: Recent Advances on Nutrition and the Prevention of Alzheimer’s Disease, Ramassamy C and Bastianetto S, eds, Transworld Reasearch Network, Kerala, India p. 1- 18, 2010.